Home

Biologics for Orthopedic Providers.

Exosomes, Wharton’s Jelly, and Mesenchymal Stem Cells applied at provider direction in conjunction with orthopedic procedures, sourced directly from an FDA-registered lab with full documentation on every order.

Joint pain is the #1 reason patients seek orthopedic care. Biologics are how you differentiate.

Orthopedic patients are researching regenerative options before they walk into your office. Providers who can explain their biologic source, show documentation, and speak to the science behind what they’re offering are converting more consultations and retaining more patients than those relying on traditional approaches alone.

Mesenchymal stem cells, exosomes, and Wharton’s Jelly each offer distinct mechanisms relevant to musculoskeletal tissue. Providers who understand the differences and can match the right product to the right application are in a stronger clinical and business position.

Clinicians offering regenerative wellness

How Biologics Integrate Into Orthopedics

ACL, MCL & Meniscal Injuries

Exosomes and Wharton’s Jelly applied at the knee joint at provider direction in conjunction with ligament and meniscal procedures. Natural collagens, hyaluronic acid, and 300+ growth factors are homologous to components naturally present in healthy ligament, meniscal, and cartilage tissue.

Joint Injections

Exosomes and Wharton’s Jelly applied at the joint space at provider direction. Natural human-derived hyaluronic acid, chondroitin sulfate, and 200+ growth factors are homologous to components naturally present in healthy synovial and cartilage tissue.

Rotator Cuff & Tendon Repair

Applied at the surgical site at provider direction. Natural collagens and ECM scaffolding from Wharton’s Jelly are homologous to components naturally present in healthy tendon and connective tissue.

Fracture & Bone Healing

MSCs and Wharton’s Jelly applied at fracture sites at provider direction. Contains viable mesenchymal stem cells capable of multi-lineage differentiation into bone, cartilage, and connective tissue.

Spine & Disc Procedures

Wharton’s Jelly applied at provider direction in conjunction with spinal procedures. ECM components and natural hyaluronic acid are homologous to those naturally present in intervertebral disc and surrounding connective tissue.

Post-Surgical Recovery

Applied at surgical sites at provider direction. Natural collagen and human-derived hyaluronic acid in a viscous scaffold matrix, keeping the full bioactive complement localized at the application site.

Revenue Potential

Model the financial impact of adding regenerative biologics to your clinical practice.

$1–4K
Avg Ticket
10–25
Monthly Volume
$120K–1.2M
Annual Potential

Products for Orthopedic Providers

Stem Cells
  • Derived from human umbilical cord tissue
  • Rich in mesenchymal stem cell-associated growth factors and cytokines
  • Sourced following AATB, FDA, and CDC guidelines
  • Processed for maximum bioactive integrity
Exosomes
  • ~350 billion exosomes per cc
  • 300+ biologically active cytokines and growth factors
  • Natural human Klotho
  • Human-derived hyaluronic acid
  • Chondroitin sulfate
FDA
FDA Registered
cGMP
cGMP Facility
ISO
Class 5 & 7 Cleanroom
MoCRA
MoCRA Compliant
Ethically Sourced

Ready to integrate human biologics into your orthopedic practice?

Get access to our full product catalog, compliance resources, and clinical documentation, built for providers who want to know exactly what’s in the vial before they use it.

Built by AUSTAN

DISCLAIMER

Sōlix does not own, operate, or manage any laboratory, manufacturing, or compounding facility. All biological products available through this platform are manufactured, processed, and distributed by our independently owned and operated FDA-registered laboratory partners. Sōlix does not distribute, ship, handle, or take possession of any biological product at any point in the supply chain.

Sōlix operates as a provider platform that offers licensed healthcare practitioners access to product ordering, clinical education, implementation support, marketing resources, and business integration tools designed to help practices incorporate regenerative biologics into their clinical offerings.

Sōlix is not a compounding pharmacy or chemical compounding facility as defined under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act. Sōlix does not compound, manufacture, repackage, or relabel any drug or biological product.

Sōlix resources are for educational and informational purposes only. Providers are responsible for their own regulatory compliance, licensing, and insurance. Sōlix assumes no liability for how materials are applied in practice.

FDA DISCLAIMER

The statements made on this website have not been evaluated by the U.S. Food and Drug Administration. The products and services referenced on this platform are not intended to diagnose, treat, cure, or prevent any disease or medical condition. Biological products, including but not limited to stem cells, exosomes, Wharton's Jelly, and amniotic tissue allografts, are minimally manipulated human cells, tissues, and cellular and tissue-based products (HCT/Ps) regulated under 21 CFR Part 1271. These products are intended for homologous use only and are administered at the sole discretion of a licensed healthcare provider following individual patient assessment. Results may vary. No guarantees of specific outcomes are made or implied.

All medical decisions, including the use of regenerative biologics, should be made in consultation with a qualified healthcare professional. Sōlix makes no medical claims and assumes no liability for clinical outcomes resulting from the use of products ordered through this platform.

Sōlix provides a provider platform and sales CRM for ordering regenerative human biologics, managing provider relationships, and integrating third-party services including Google Calendar for scheduling and appointment management. For details on how we handle your data, see our Privacy Policy.

Terms & ConditionsPrivacy Policy